Publication Type : Journal Article
Thematic Areas : Nanosciences and Molecular Medicine
Publisher : Curr Med Chem, Bentham Science Publishers B.V.,
Source : Curr Med Chem, Bentham Science Publishers B.V., Volume 24, Issue 31, Number 31, p.3413-3432 (2017)
Keywords : Animals, coronary artery disease, Fibroblast Growth Factors, Humans, Intercellular Signaling Peptides and Proteins, Neovascularization, Physiologic, Peptides, Polysaccharides, Small Molecule Libraries, Vascular Endothelial Growth Factors
Campus : Kochi
School : Center for Nanosciences, School of Dentistry
Center : Amrita Center for Nanosciences and Molecular Medicine Move, Nanosciences
Department : Periodontics, Nanosciences and Molecular Medicine
Year : 2017
Abstract : BACKGROUND: Therapeutic angiogenesis is a clinical intervention for controlled stimulation and augmentation of neovascularisation in ischemic tissues. Conventional therapeutic techniques involve proangiogenic factor based induction of host tissue angiogenesis. In this review, we provide a holistic idea about therapeutic angiogenesis while specifically highlighting the role of proangiogenic factors as growth factors, peptides, small molecules and polysaccharides in tissue neovascularisation./ppbMETHODS: /bA detailed search of peer-reviewed literature was carried out with prime focus on therapeutic angiogenesis and proangiogenic factors. The content of each literature reviewed in this paper was qualitatively analysed for particulars and relevance to the subject of study. This work has been distributed under four broad titles, namely, proangiogenic growth factors, peptides, small molecules and polysaccharides. Also, recent developments pertaining to proangiogenic factors for therapeutic angiogenesis have been detailed./ppbRESULTS: /bA total of 244 literatures have been reviewed from the bibliographic database to present a conceptual understanding about the importance of proangiogenic factors in revascularisation of ischemic tissues./ppbCONCLUSION: /bThis review focuses on importance of various proangiogenic factors, with reference to therapeutic angiogenesis. Thorough analysis of clinical data reveals the dearth of a defined system for proangiogenic growth factor delivery. Designing of a biomaterial based paradigm for growth factor therapy, might help in enhancing clinical translation of therapeutic angiogenesis.
Cite this Research Publication : V. Selvaprithviraj, Sankar, D., Sivashanmugam, A., Sowmya Srinivasan, and Dr. Jayakumar Rangasamy, “Pro-angiogenic Molecules for Therapeutic Angiogenesis.”, Curr Med Chem, vol. 24, no. 31, pp. 3413-3432, 2017.